Patent application number | Description | Published |
20080213317 | AVIAN E. COLI VACCINE FOR PROTECTION AGAINST COLIBACILLOSIS - A genetic deletion mutant live | 09-04-2008 |
20080226676 | Multivalent avian influenza vaccines and methods - The present invention provides vaccine compositions comprising at least two strains of avian influenza virus, wherein one of the strains has an H5 hemagglutinin subtype and the other strain has an H7 hemagglutinin subtype, and wherein at least one of the strains has an N4 neuraminidase subtype and neither strain has an N1 subtype. Also provided are vaccination methods that utilize the novel vaccine compositions of the invention. The compositions and methods of the present invention provide protection against infection with H5 and H7 influenza strains (e.g., H5N1 and H7N1) while at the same time facilitating the distinction between infected and vaccinated animals. | 09-18-2008 |
20080241192 | Vaccination against multiple serotypes of pasteurella multocida - The present invention provides methods for inducing cross-protective immunity against virulent strains of | 10-02-2008 |
20090017067 | EMULSION VACCINE COMPOSITIONS COMPRISING ANTIGEN AND ADJUVANT IN THE AQUEOUS PHASE - Emulsion vaccine formulations containing an antigen and an adjuvant in the aqueous phase are used for the vaccination of animals wherein the adjuvant is an acrylic polymer and/or dimethyl dioctadecyl ammonium bromide (DDA). These formulations can be prepared by mixing an aqueous phase containing the antigen and adjuvant with an oil phase in the presence of an emulsifier. | 01-15-2009 |
20090068231 | LIVE ATTENUATED MYCOPLASMA STRAINS - The present invention provides live, attenuated | 03-12-2009 |
20090068232 | ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS - The present invention provides live, attenuated | 03-12-2009 |
20110123560 | Infectious Bursal Disease Virus Antigenic Isolates And Vaccines - Antigenic isolates and vaccines for Infectious Bursal Disease Virus include variants of the molecular Group 6 family of IBDV isolates, in particular the 28-1 isolate. | 05-26-2011 |
20120045476 | LIVE ATTENUATED MYCOPLASMA STRAINS - The present invention provides live, attenuated | 02-23-2012 |